Exosomes Released by Cerebrolysin-Treated Cerebral Endothelial Cells Reverse Fibrin- or tPA-Impaired Endothelial Cell Permeability
Cells · 19.05.2026 · 15 (10) · 934
DOI: 10.3390/cells15100934 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 19.05.2026. Verfasst von Hua Teng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Henry Ford Health, Detroit, MI 48202, USA. Hauptthemen laut MEDLINE: Tissue Plasminogen Activator, Endothelial Cells, Exosomes, Fibrin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EVER Pharma GmbH, Oberburgau 3, Unterach, Austria., EVER Pharma GmbH.
Abstract (Originalsprache)
Cerebrolysin has a salutary effect on impaired cerebral endothelial cell (CEC) permeability. Using an in vitro endothelial permeability assay, the present study tested the hypothesis that exosomes released by Cerebrolysin-treated CECs (Cerebro-Exos) have a robust therapeutic effect on dysfunctional CECs. Stoichiometric analysis showed marked differences in cargo profiles between Cerebro-Exos and exosomes derived from CECs without Cerebrolysin treatment (Naïve-Exos), in which Cerebro-Exos were highly enriched with metabolic and tight junction related proteins compared to Naïve-Exos. Cerebro-Exos had a superior effect compared to Naïve-Exos on restoring CEC integrity impaired by fibrin and tissue plasminogen activator (tPA). Treatment of fibrin- and tPA-challenged CECs with Cerebro-Exos robustly reduced fibrin- and tPA-augmented proteins involved in inflammation and coagulation and substantially increased fibrin- and tPA-decreased proteins that are related to tight junctions and metabolism. Collectively, these data indicate that Cerebro-Exos have a broad effect on improvement of dysfunctional CECs, which is likely achieved by the alteration of CEC proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Henry Ford Health, Detroit, MI 48202, USA.
- Department of Physics, Oakland University, Rochester, MI 48309, USA.
ORCID-Profile: Hua Teng, Chao Li, Mingjin Wang, Yi Zhang, Michael Chopp, Zheng Gang Zhang
Förderung
- EVER Pharma GmbH, Oberburgau 3, Unterach, Austria.
- EVER Pharma GmbH
Zitieren
APA
Teng, H., Li, C., Wang, M., Zhang, J., Zhang, Y., Chopp, M., & Zhang, Z. G. (2026). Exosomes Released by Cerebrolysin-Treated Cerebral Endothelial Cells Reverse Fibrin- or tPA-Impaired Endothelial Cell Permeability. Cells, 15(10), 934. https://doi.org/10.3390/cells15100934
Vancouver
Teng H, Li C, Wang M, Zhang J, Zhang Y, Chopp M, et al. Exosomes Released by Cerebrolysin-Treated Cerebral Endothelial Cells Reverse Fibrin- or tPA-Impaired Endothelial Cell Permeability. Cells. 2026;15(10):934. doi:10.3390/cells15100934
BibTeX
@article{Teng2026,
author = {Teng, Hua and Li, Chao and Wang, Mingjin and Zhang, Jing and Zhang, Yi and Chopp, Michael and Zhang, Zheng Gang},
title = {Exosomes Released by Cerebrolysin-Treated Cerebral Endothelial Cells Reverse Fibrin- or tPA-Impaired Endothelial Cell Permeability},
journal = {Cells},
year = {2026},
volume = {15},
number = {10},
pages = {934},
doi = {10.3390/cells15100934}
}
EUVIMED